Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study

Forschner, Andrea; Weissgraeber, Stephanie; Hadaschik, Dirk; Schulze, Martin; Kopp, Maria; Kelkenberg, Sabine; Sinnberg, Tobias; Garbe, Claus; Biskup, Saskia; Battke, Florian

dc.contributor.author	Forschner, Andrea Lydia
dc.contributor.author	Sinnberg, Tobias
dc.contributor.author	Garbe, Claus
dc.date.accessioned	2020-11-02T15:25:24Z
dc.date.available	2020-11-02T15:25:24Z
dc.date.issued	2020
dc.identifier.issn	1178-6930
dc.identifier.uri	http://hdl.handle.net/10900/109071
dc.language.iso	en	de_DE
dc.publisher	Dove Medical Press Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.2147/OTT.S248237	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker Study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_02094
utue.publikation.seiten	5017-5032	de_DE
utue.personen.roh	Forschner, Andrea
utue.personen.roh	Weissgraeber, Stephanie
utue.personen.roh	Hadaschik, Dirk
utue.personen.roh	Schulze, Martin
utue.personen.roh	Kopp, Maria
utue.personen.roh	Kelkenberg, Sabine
utue.personen.roh	Sinnberg, Tobias
utue.personen.roh	Garbe, Claus
utue.personen.roh	Biskup, Saskia
utue.personen.roh	Battke, Florian
dcterms.isPartOf.ZSTitelID	Oncotargets and Therapy	de_DE
dcterms.isPartOf.ZS-Volume	13	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE